Natural killer cell receptor NKG2D (NKG2D)

Natural killer cell receptor NKG2D is a transmembrane activating receptor expressed primarily on NK cells and subsets of T cells (notably CD8+ T, γδ T, and disease-activated CD4+ T cells in humans)[1][5][3]. It belongs to the C-type lectin-like receptor family and is encoded by the KLRK1 gene. NKG2D recognizes "induced-self" ligands—mainly MICA, MICB, and ULBP family members in humans—whose expression is upregulated on the surface of cells under cellular stress, transformation (cancer), infection, or DNA damage. When engaged by these ligands, NKG2D triggers potent cytotoxicity and cytokine secretion, contributing to immune surveillance and the elimination of malignant or infected cells. Signal transduction requires association with the adaptor protein DAP10 in humans, and both DAP10 and DAP12 in mice, relying on downstream effectors like PI3K, Vav1, and Syk/ZAP70 kinases for intracellular signaling[1][5][3]. NKG2D functions as a *master regulator* of immune cell activation thresholds—coordinating responses by integrating activating and inhibitory signals, and is central to innate and adaptive immunity[3]. Its role is implicated in cancer immunotherapy, infection defense, autoimmunity, and transplant biology, though modulation of its pathway carries notable safety challenges[5][3][6][2][8].

Other names

Killer cell lectin-like receptor subfamily K member 1 (KLRK1)NKG2-DCD314NK cell receptor NKG2D

Activation of NK cell-mediated cytotoxicity via ligand engagement on transformed, infected, or stressed cells[5][1][3]. Co-stimulatory signaling for T cell activation[1][3]. Initiation of cytokine secretion such as IFN-gamma and GM-CSF[2][5].